CATALYST DOSSIER · UPDATED 2026-11-05
$CATX
biotech · convergence 0 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $CATX?
Quantitative
Net Income (CY2026Q2) : $-26.8M (-24.7% YoY)
Catalysts
Multi-spoke convergence : 7 convergent signals fired: earnings, finra_short, finra_regsho, sec_fda, auto_macro_adp_payrolls
Risks
Hard-to-borrow / FTD risk : Borrow rate 6.0%, distress score 30
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
APP via tech r=+0.81 sympathetic (score 19)
STEM via tech r=+0.81 sympathetic (score 19)
LBTYA via comms r=+0.62 sympathetic (score 16)
CHTR via comms r=+0.62 sympathetic (score 7)
Signals Firing
earnings finra_short finra_regsho sec_fda auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-23 sec_top_gappers -1.2% -24.8% — 2026-10-23 sec_top_moat_emerging -1.2% -24.8% — 2026-10-01 sec_clean_gappers +3.7% +1.5% ✓ hit 2026-10-01 sec_top_gappers +3.7% +1.5% ✓ hit 2026-10-01 sec_top_moat_emerging +3.7% +1.5% ✓ hit 2026-09-15 sec_top_gappers +0.7% -1.1% — 2026-09-15 sec_top_moat_emerging +0.7% -1.1% — 2026-09-14 sec_clean_gappers -1.0% -6.5% — 2026-09-14 sec_top_gappers -1.0% -6.5% — 2026-09-14 sec_top_moat_emerging -1.0% -6.5% —
Lifetime: 3/10 wins · hit-rate 30.0% on +2% intraday
Sympathy Basket APP via tech · score 19 STEM via tech · score 19 LBTYA via comms · score 16 CHTR via comms · score 7
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.